ABG Analytics logo
Get updates

Gilead Sciences Inc (NASDAQ: GILD)

DRUGS - Biotechnology
Sector: Health Care
Stock price data as of 12/23/2022
Closing price: 84.75
Support price level: $73.03
Resistance price level: N/A
Relative strength index (14-day RSI) 33.1
Beta 0.38
  • The price of this low-beta stock is expected to increase by 0.38% for every 1% increase in the S&P-500.

  • Volatility is forecast to fall over the next month.

  • GILD is above its 200-day moving average, providing a measure of support for long positions.

  • Price broke above prior resistance level - a short-term bullish signal.

Low High Price as % of Range
$57.72 $89.47 87.6%
200 day 50 day 20 day 10 day
$67.05 $81.28 $87.12 $86.55
(Annualized standard deviation)
Historical
(5 year)		 Last month Current estimate Next month forecast
26.0% 30.9% 22.8% 23.9%
There is an estimated 5% probability that the stock price of Gilead Sciences Inc will fall by more than:
  • 6.2% in the next week.

  • 13.5% in the next month.

  • 42.7% in the next year.